Semaglutide: a beginner-friendly guide to the GLP-1 behind Ozempic and Wegovy
Semaglutide is the active ingredient in two of the most talked-about weight loss medications. Here is what it actually does, how it is dosed, and what the first 12 weeks usually look like.
Key points
- Semaglutide mimics GLP-1, a gut hormone that signals fullness and slows digestion.
- Dosing starts low (0.25 mg) and titrates up over several weeks to limit side effects.
- Average trial results show 12-15% body weight reduction at 68 weeks with lifestyle support.
- It is a tool, not a shortcut — nutrition, sleep, and movement still drive long-term outcomes.
What semaglutide is, in plain English
Semaglutide is a once-weekly injectable medication in a class called GLP-1 receptor agonists. Your body already makes GLP-1 — it is a hormone released by the gut after you eat that tells your brain you are full and tells your stomach to empty more slowly. Semaglutide is a long-acting version of that same signal.
It is the active ingredient in Ozempic (FDA-approved for type 2 diabetes) and Wegovy (FDA-approved for chronic weight management). Same molecule, different branded doses and indications.
How the first 12 weeks typically go
Most patients start at 0.25 mg once weekly for four weeks. This starting dose is intentionally too low to produce much weight loss — it is a tolerance-building step to reduce nausea, which is the most common side effect.
Dosing then steps up every four weeks, usually through 0.5 mg, 1.0 mg, 1.7 mg, and eventually 2.4 mg if you are on the Wegovy schedule. Most people feel meaningful appetite suppression by week 4-6 and see the scale start to move shortly after.
Side effects — nausea, constipation, fatigue, occasional reflux — are usually worst in the first few days after a dose increase and fade over the following week. If they do not, a slower titration almost always fixes it.
What it will not do on its own
GLP-1s are powerful, but they are not magic. The patients who do best on semaglutide treat it as scaffolding: the medication makes it easier to eat less and crave less, and they use that window to rebuild nutrition, strength training, and sleep habits that will outlast the prescription.
If you come off the medication without those habits in place, regain is common. If you have them, the medication becomes a bridge rather than a crutch.
Is it right for you?
Semaglutide is generally considered for adults with a BMI of 30+, or 27+ with a weight-related condition like prediabetes, hypertension, or sleep apnea. It is not recommended if you have a personal or family history of medullary thyroid carcinoma or MEN2.
A licensed clinician should always review your history before prescribing — that is not a formality, it is where your plan actually gets personalized.